The Israeli developer of a belt-like device that monitors the health of both a pregnant woman and her fetus has merged with a U.S. firm to create a new combined company.

Nuvo’s FDA-cleared device INVU is worn around the belly of the expectant mother and uses central and acoustic sensors to measure fetal ‎movements, fetal heart rate and maternal heart rate.

The Tel Aviv-based company has merged with California-headquartered LAMF Global Ventures, and the new entity will retain the Nuvo name and existing operational and management structure. It will also be publicly traded on the NASDAQ Stock Market as NUVO, beginning May 2.

Nuvo CEO Rice Powell will become the head of the combined company,

The device is in use in both Israel and the United States, and the company is planning to expand into Europe this year, having filed a request for European Union approval in March 2023.

Keep reading at

Nuvo Cares CTO Amit Reches is a Technion alumnus.